Kaya Holdings (KAYS) Net Income towards Common Stockholders (QoQ) (2012 - 2025)
Kaya Holdings (KAYS) Net Income towards Common Stockholders (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -242.92% |
| Jun 30, 2025 | -49.36% |
| Mar 31, 2025 | -50.18% |
| Dec 31, 2024 | 55.24% |
| Sep 30, 2024 | -798.56% |
| Jun 30, 2024 | 132.31% |
| Mar 31, 2024 | -1,940.35% |
| Dec 31, 2023 | -91.45% |
| Sep 30, 2023 | 17.37% |
| Jun 30, 2023 | 791.09% |
| Mar 31, 2023 | 100.75% |
| Dec 31, 2022 | -220.86% |
| Sep 30, 2022 | 141.55% |
| Jun 30, 2022 | 379.60% |
| Mar 31, 2022 | 91.64% |
| Dec 31, 2021 | -432.22% |
| Sep 30, 2021 | -56.94% |
| Jun 30, 2021 | 266.24% |
| Mar 31, 2021 | -263.13% |
| Dec 31, 2020 | 125.25% |